Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Single-Arm Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy

NCT07019922 is registered in ClinicalTrials.gov with Praxis Precision Medicines as lead sponsor.

NCT NCT07019922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07019922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Single-Arm Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
Lead sponsor
Praxis Precision Medicines
Phase
Phase 3
Overall status
Recruiting
Start date
August 13, 2025
Completion date
December 31, 2028
Enrollment
40 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

epileptic encephalopathy, scn2a encephalopathy